|
Volumn 48, Issue 7, 2004, Pages 2782-2783
|
Pharmacokinetics of oral valganciclovir and intravenous ganciclovir administered to prevent cytomegalovirus disease in an adult patient receiving small-intestine transplantation [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
AZATHIOPRINE;
BASILIXIMAB;
CORTICOSTEROID;
CREATININE;
GANCICLOVIR;
IMMUNOSUPPRESSIVE AGENT;
TACROLIMUS;
VALGANCICLOVIR;
ADULT;
AREA UNDER THE CURVE;
CASE REPORT;
CREATININE CLEARANCE;
CYTOMEGALOVIRUS INFECTION;
DESMOID TUMOR;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG METABOLISM;
FEMALE;
GRAFT REJECTION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE TRANSPLANTATION;
KIDNEY FUNCTION;
LETTER;
NEPHROTOXICITY;
PRIORITY JOURNAL;
SMALL INTESTINE;
VIRUS CULTURE;
VIRUS INFECTION;
ADMINISTRATION, ORAL;
ADULT;
ANTIVIRAL AGENTS;
AREA UNDER CURVE;
BIOLOGICAL AVAILABILITY;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CYTOMEGALOVIRUS INFECTIONS;
FEMALE;
GANCICLOVIR;
HUMANS;
INJECTIONS, INTRAVENOUS;
INTESTINE, SMALL;
|
EID: 3042616776
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.48.7.2782-2783.2004 Document Type: Letter |
Times cited : (15)
|
References (5)
|